Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Class of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up
February 28, 2025
Via
Investor's Business Daily
Tickers
HIMS
LLY
NVO
Exposures
Product Safety
Altimmune Retail Buzz Heats Up On MASH Progress, FDA Nod For New Trials: Stock Jumps After Q4 Print
February 27, 2025
Via
Stocktwits
Tickers
ALT
IWM
VTI
XBI
Exposures
Product Safety
Together in the Fight Against Cancer: Thomas’ Story of Community and Care
February 27, 2025
Via
Syndication Cloud
Topics
Product Recall
Exposures
Legal
Product Safety
Viatris Stock Tumbles On Q4 Earnings Miss, FDA Warning Clouds 2025 Outlook
February 27, 2025
Via
Benzinga
Topics
Earnings
Tickers
VTRS
Exposures
Financial
Product Safety
Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
February 27, 2025
Via
MarketBeat
Tickers
LLY
NVO
REGN
SNY
Exposures
Product Safety
Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision
February 26, 2025
Via
Benzinga
Topics
Lawsuit
Tickers
LLY
NVO
Exposures
Financial
Legal
Product Safety
Zero Calorie Clean Energy Caffeine Drink For Police & First Responders Announced
February 26, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
How to choose a cleanroom that meets FDA standards?
February 26, 2025
Via
AB Newswire
Exposures
Product Safety
Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
February 26, 2025
Via
MarketBeat
Tickers
LLY
NVO
PFE
RHHBY
Exposures
Product Safety
From Desperation to Design: Renowned Jewelry Designer, Danielle Nicole Enright Seeks Her Pay It Forward Angel
February 25, 2025
Via
PRLog
Topics
Product Recall
Exposures
Legal
Product Safety
Arthrosamid Hydrogel Injections, Safe Alternative to Knee Surgery Report Launch
February 25, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
Lung Disease-Focused Insmed 'Is An Attractive Midcap Biotech,' Analyst Says
February 25, 2025
Via
Benzinga
Tickers
INSM
RY
TSX:RY
Exposures
Product Safety
Loyal Saints: Revolutionizing Dog Nutrition with Premium, Freeze-Dried Raw Food
February 25, 2025
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Partners with APST Research to Advance ALS Drug Approval Process
February 25, 2025
Via
Investor Brand Network
Tickers
CLNN
Exposures
Product Safety
EXCLUSIVE: After FDA Response, Adial Starts Manufacturing Clinical Supplies For Upcoming Phase 3 Program Of Lead Candidate For Alcohol Use Disorder
February 25, 2025
Via
Benzinga
Tickers
ADIL
Exposures
Product Safety
Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment
February 25, 2025
Via
News Direct
Tickers
NLSP
Exposures
Product Safety
Bristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review
February 24, 2025
Via
Benzinga
Tickers
BMY
Exposures
Product Safety
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
February 24, 2025
Via
Benzinga
Tickers
MDT
Exposures
Product Safety
FDA Clears Entrada Therapeutics' Early-Stage For Potential Treatment Of Duchenne Muscular Dystrophy
February 24, 2025
Via
Benzinga
Tickers
TRDA
Exposures
Product Safety
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients
February 24, 2025
Via
Benzinga
Tickers
IVVD
Exposures
COVID-19
Product Safety
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery
February 24, 2025
Via
Benzinga
Tickers
GKOS
Exposures
Product Safety
Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version
February 24, 2025
Via
Benzinga
Tickers
CODX
Exposures
COVID-19
Product Safety
REMSleep Prepares to Launch New FDA Cleared CPAP Pillows Mask to Market
February 24, 2025
Via
NewMediaWire
Tickers
RMSL
Exposures
Product Safety
REMSleep Prepares to Launch New FDA Cleared CPAP Pillows Mask to Market
February 24, 2025
Via
TheNewswire.com
Tickers
RMSL
Exposures
Product Safety
From Vehicle Factory Codes to Smart Decisions: The Power of VIN Decoders
February 24, 2025
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
Skincare Brands US Market Entry Support: Business Registration, Marketing Update
February 21, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
FDA Approves Mirum Pharmaceuticals' Drug As First For Genetic Disorder With Inability To Break-Down Cholesterol
February 21, 2025
Via
Benzinga
Tickers
MIRM
Exposures
Product Safety
What's Going On With Hims & Hers Health Stock Today?
February 21, 2025
Via
Benzinga
Topics
Economy
Tickers
HIMS
Exposures
Product Safety
Supply Chain
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
February 21, 2025
Via
Investor's Business Daily
Tickers
HIMS
LLY
NVO
Exposures
Product Safety
Elon Musk's Tesla Recalls Nearly 380,000 Model 3, Y Vehicles In US Over Loss Of Power Steering Assist Concerns
February 21, 2025
Via
Benzinga
Topics
Product Recall
Tickers
TSLA
Exposures
Legal
Product Safety
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.